Respiratory failure

Respiratory failure is the point at which the lungs and respiratory muscles can no longer maintain adequate gas exchange — meaning the blood is not receiving enough oxygen, carbon dioxide is not being cleared, or both. In a depressant drug context, it is the endpoint of respiratory depression: the gradual suppression of the drive to breathe has progressed to the point where the body's compensatory mechanisms can no longer keep up.

The respiratory control system sits largely in the brainstem, which monitors blood carbon dioxide levels and adjusts breathing rate and depth accordingly. Opioids, benzodiazepines, alcohol, barbiturates, and related central nervous system depressants act on this circuitry, dulling its sensitivity. At sufficient load — or when multiple depressants are combined — this suppression can advance from slowed breathing to absent breathing.

How it is done

Respiratory failure in a depressant context typically develops over minutes to hours. Breathing slows and becomes shallower. The person becomes difficult to rouse, then unresponsive. The lips, fingertips, or face may take on a blue or grey tint — a sign that oxygen in the blood is falling. Breathing may grow irregular, producing slow gasps or gurgling sounds as airway muscle tone is lost.

These changes can appear gradually or accelerate quickly, particularly when multiple depressants are active at once. A person who appears merely sedated can transition into respiratory failure without clear warning.

When it matters

Absent or near-absent breathing in an unresponsive person is a medical emergency, and the window in which oxygen deprivation begins causing brain damage is short.

If opioids are among the substances involved, naloxone is administered immediately. Placing an unresponsive person on their side — the recovery position — keeps the airway clear while help arrives. If breathing has stopped entirely and trained responders are present, rescue breathing is started. Emergency services are contacted regardless of whether naloxone appears to have worked, because the reversal may be temporary and the underlying depressant load may outlast it.

What it cannot tell you

Observing the signs of respiratory failure does not reveal its cause, and the cause matters for the response. Naloxone, the opioid reversal agent, addresses only the opioid component of respiratory depression. If alcohol, benzodiazepines, or other non-opioid depressants are contributing, naloxone may improve breathing without fully restoring it — or may produce an apparent recovery followed by relapse as the naloxone clears before the depressant does.

There is also no way to assess from the outside how long inadequate oxygenation has been occurring, or whether it will recur. Long-acting opioids outlast a single dose of naloxone; a person who begins breathing after reversal may stop again. Apparent recovery is not a signal that the situation has resolved.